Amyloidosis and Alzheimer’s disease
- 7 December 2002
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 54 (12), 1539-1551
- https://doi.org/10.1016/s0169-409x(02)00149-7
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Protein dynamics, folding and misfolding: from basic physical chemistry to human conformational diseasesFEBS Letters, 2001
- Regional Distribution of Amyloid-Bri Deposition and Its Association with Neurofibrillary Degeneration in Familial British DementiaThe American Journal of Pathology, 2001
- In Vitro Creation of Amyloid Fibrils from Native and Arg124Cys Mutated βIGH3(110–131) Peptides, and Its Relevance for Lattice Corneal Amyloid Dystrophy Type IBiochemical and Biophysical Research Communications, 2000
- Protein misfolding and prion diseasesJournal of Molecular Biology, 1999
- Alzheimer's soluble amyloid β is a normal component of human urineFEBS Letters, 1997
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Apolipoprotein E: Binding to Soluble Alzheimer′s β-AmyloidBiochemical and Biophysical Research Communications, 1993
- Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formationBiochemical and Biophysical Research Communications, 1991
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991
- Hereditary cerebral hemorrhage with amyloidosis — Dutch typeClinical Neurology and Neurosurgery, 1989